FIBROBIOLOGICS INC FBLG

US Healthcare Pharmaceutical Preparations
$0.88
-3.3%
52w: $0.73 – $8.74

Latest 13F among current holders filed 3 days ago (Oct 29, 2026)

Price — last 12 months

research preview data
0.734.748.74
Oct 17, 2025 Jul 2, 2026
Institutional holders
18
+17 QoQ
13F value
$291K
+4158871.4% QoQ
Smart-money holders
0
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$7
Q2 2025
$291K
Q1 2026

Number of holders

1
Q2 2025
18
Q1 2026

Who owns FBLG?

Q1 2026 filings
FundTypeSharesValue% of fundChange
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical67.7K$89K——
Fund Evaluation Group, LLC Wealth advisor51.8K$68K—New
GEODE CAPITAL MANAGEMENT, LLC Index provider29.6K$39K—New
BlackRock, Inc. Index provider24.6K$33K0.0%New
Cascade Financial Partners, LLC Wealth advisor16.4K$22K0.0%New
RENAISSANCE TECHNOLOGIES LLC Quant stat arb16.0K$21K—New
VANGUARD FIDUCIARY TRUST CO Diversified mechanical6.4K$8K——
UBS Group AG Bank broker5.7K$8K0.0%New
NewEdge Advisors, LLC Diversified mechanical845$1K0.0%New
Vanguard Global Advisers, LLC Diversified mechanical536$708——
Tower Research Capital LLC (TRC) Market maker460$6070.0%New
ISLAY CAPITAL MANAGEMENT, LLC Wealth advisor169$223—New
OSAIC HOLDINGS, INC. Wealth advisor154$2030.0%New
BNP PARIBAS FINANCIAL MARKETS Bank broker66$870.0%New
BFC Planning, Inc. —50$660.0%New
Allworth Financial LP Wealth advisor13$180.0%New
WELLS FARGO & COMPANY/MN Bank broker10$130.0%New
ROYAL BANK OF CANADA Bank broker186$00.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.